“Should” outdueled “may” as US Centers for Disease Control and Prevention advisors recommended children age 12 to 17 who received the Pfizer Inc./BioNTech SE COVID-19 vaccine also obtain a booster.
The Advisory Committee on Immunization Practices voted 13-1 on 5 January that the CDC use its strongest possible language to encourage the additional jab for 12- to 15-year-olds and elevated...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?